[ad_1]
Pfizer announced to the FDA, the US Food and Drug Administration, that an application has been submitted to allow the emergency use of the COVID-ip vaccine.
If approved by the FDA, the vaccine will begin next month. Thus, the first step in the process that will end global respect will be taken.
Pfizer and BioNTech had announced that the vaccine was 95 percent effective. The FDA grants “emergency use approval” to drugs or vaccines whose final testing phase is not fully completed.
The agency continues to monitor the vaccine or drug for final approval, even though it gives the green light for emergency use.
Pfizer has applied for approval in Europe and the UK. The first vaccine in the United States is expected to come under attack in early December, if the FDA passes.
General Gustave Perna, leading the operation against the virus, which the Trump administration called “speed of light,” said the vaccine will be distributed quickly if the go-ahead is issued.
Approximately 25 million vaccines will be available in the United States in December.
The vaccine should be given in two doses, three weeks apart.
The vaccine from Moderna, another US pharmaceutical company, is also expected to undergo FDA approval in a few weeks.
